Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd

$KRSNAAHealthcare Service ProviderNSEBSE

Krsnaa Diagnostics Ltd (KRSNAA) last traded at ₹560, a market capitalisation of ₹1,816 crore, on a P/E of 18.6. Over the past 52 weeks the stock has ranged between ₹502 and ₹894. Krsnaa Diagnostics Ltd last reported results for the quarter ended Jun 2026, with sales of ₹236 crore and net profit of ₹17 crore. The next scheduled event is a preferential issue on 17 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Krsnaa Diagnostics Ltd share price and key metrics

Current price
₹560
Market cap
₹1,816 cr
Stock P/E
18.6
Book value
₹302
ROE
10.9%
ROCE
12.7%
Dividend yield
0.36%
52w high / low
894/502

Metrics as of 25 Aug 2026. Not real time.

Krsnaa Diagnostics Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹236 cr, up 22.3% from ₹193 cr a year earlier. Net profit was ₹17 cr, down 19.0% year on year.

Krsnaa Diagnostics Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales186175186193206181193236
Expenses137129133142147135138178
Operating profit4945535159465558
OPM %27%26%28%27%29%26%28%25%
Other income594444327
Interest6676881215
Depreciation2223222224232328
Profit before tax2525292732205222
Tax %23%24%28%25%24%23%19%26%
Net profit2019212124154217
EPS (₹)6.076.016.406.337.384.7012.865.10

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Krsnaa Diagnostics Ltd annual results

Krsnaa Diagnostics Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales61455487620717773815
Operating profit19132122144190212218
OPM %31%29%25%23%27%27%27%
Net profit-06862577810197
EPS (₹)-0.1421.7819.7817.6024.0431.2730.04

TTM is the trailing twelve months to the most recent quarter.

Krsnaa Diagnostics Ltd growth and returns

Compounded Sales Growth
10 Years
35%
5 Years
%
3 Years
17%
TTM
10%
Compounded Profit Growth
10 Years
37%
5 Years
%
3 Years
18%
TTM
22%
Stock Price CAGR
10 Years
%
5 Years
-9%
3 Years
-1%
1 Year
-30%
Return on Equity
10 Years
%
5 Years
9%
3 Years
9%
Last Year
11%

Krsnaa Diagnostics Ltd shareholding pattern

Promoters held 27.11% at Jun 2026, broadly unchanged since Jun 2025. FIIs 4.28% and DIIs 14.51%.

Krsnaa Diagnostics Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters27.17%27.24%27.24%27.11%27.11%27.11%27.11%27.11%
FIIs3.63%4.04%3.55%3.40%3.66%4.17%3.91%4.28%
DIIs15.86%14.46%14.26%14.24%14.96%13.85%13.89%14.51%
Public53.34%54.27%54.94%55.25%54.27%54.86%55.09%54.08%
No. of shareholders53,51952,79953,55954,26252,11752,38053,02253,625

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Krsnaa Diagnostics Ltd events

The next scheduled event is a preferential issue on 17 Sept 2026.

  • Preferential issueIssuance of 16,21,000 warrants to promoters on a preferential basis
  • AGM16th Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Krsnaa Diagnostics Ltd corporate filings

  • Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Ltd has submitted a general announcement under Regulation 30 of the…

    Read the full analysis
  • Transcript of Earnings Call for quarter ended June 30, 2026Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Limited reported Q1 FY27 revenue of 235.5 crore, a 22% YoY increase…

    Read the full analysis
  • Newspaper Advertisement for Postal BallotCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Ltd has issued a newspaper advertisement regarding a Postal Ballot…

    Read the full analysis
  • Notice of Postal Ballot for Preferential Issue of WarrantsAGM/EGMhigh impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Limited has announced a preferential issue of up to 16.21 lakh…

    Read the full analysis
  • Newspaper advertisement pertaining to the Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30, 2026Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Limited reported Q1 FY27 standalone and consolidated financial…

    Read the full analysis
  • Earnings Call Recording for Quarter ended June 30, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Limited has formally disclosed the audio recording of its earnings…

    Read the full analysis
  • Investor PresentationCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics reported Q1 FY27 revenue of 235.5 crore, a 22% increase YoY from 193…

    Read the full analysis
  • Press ReleaseCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Ltd has submitted a press release under Regulation 30 of the SEBI…

    Read the full analysis
  • Outcome of Board Meeting held on August 13, 2026Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Limited reported consolidated revenue of 235.53 crore for the quarter…

    Read the full analysis
  • Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Ltd has issued an intimation regarding an upcoming analyst/investor…

    Read the full analysis
  • Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the unaudited standalone ....Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Krsnaa Diagnostics Limited has scheduled a board meeting for August 13, 2026, to approve…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Krsnaa Diagnostics Ltd

Cruxal reads every Krsnaa Diagnostics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Krsnaa Diagnostics Ltd (KRSNAA) Results, Financials & Share Price | Cruxal